The second #ICR10 scientific achievement of 2018/19 was the result of a major international trial that showed targeted drug palbociclib extends #BreastCancer survival. In our video Professor Nicholas Turner talks about the trial. Read more about this story: https://www.icr.ac.uk/news-features/latest-features/scientific-achievements-of-2019/#2 | The Institute of Cancer Research

The collateral damage of breast cancer treatment Palbociclib is destroying my tongue There is no treatment There are things that can help to ease the burning and the stinging and the pain but they can’t stop it happening The thought of living like this for the rest of my life is unbearable. Is it worth it in the hope that Palbo stops me getting stage 4 disease…? I don’t know what to do | Dr Liz O'Riordan